Ipsen Targets External Innovation With Exicure Option In Rare Neurodegenerative Disorders

Pacts In Huntington's Disease, Angelman Syndrome

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.